elaboration. Aspirin can also directly scavenge hydroxyl radicals to form the 2, 3-and 2, 5- dihydroxybenzoate derivatives, which themselves serve as markers of oxidative stress25 …
M Gilard, P Barragan, AAL Noryani, HA Noor… - Journal of the American …, 2015 - jacc.org
Background: The currently recommended duration of dual antiplatelet therapy (DAPT) in drug-eluting stent (DES) recipients is 12 months to reduce the risk of late stent thrombosis …
JP Bassand, CW Hamm, D Ardissino… - European heart …, 2007 - academic.oup.com
The content of these European Society of Cardiology (ESC) Guidelines has been published for personal and educational use only. No commercial use is authorized. No part of the ESC …
M Pignone, MJ Alberts, JA Colwell, M Cushman… - Circulation, 2010 - Am Heart Assoc
The burden of cardiovascular disease (CVD) among patients with diabetes is substantial. Individuals with diabetes are at 2-to 4-fold increased risk of cardiovascular events compared …
PA Gum, K Kottke-Marchant, PA Welsh, J White… - Journal of the American …, 2003 - jacc.org
Objectives: This study was designed to determine if aspirin resistance is associated with clinical events. Background: Aspirin resistance, defined by platelet function testing and …
Objective To determine if there is a relation between aspirin “resistance” and clinical outcomes in patients with cardiovascular disease. Design Systematic review and meta …
Aspirin resistance is the inability of aspirin to reduce platelet production of thromboxane A 2 and thereby platelet activation and aggregation. Increasing degrees of aspirin resistance …
L Badimon, G Vilahur, B Rocca… - Cardiovascular …, 2021 - academic.oup.com
Arachidonic acid is one of the most abundant and ubiquitous ω-6 polyunsaturated fatty acid, present in esterified form in the membrane phospholipids of all mammalian cells and …
This article discusses platelet active drugs as part of the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based …